Lalwani Nikhil

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
10 10% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 109%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Lalwani Nikhil's trades of ANI Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
70.40
Quantity 5,400
Value US$380,160
Transaction date
Proposed sale
Price
74.17
Quantity 5,400
Value US$400,518
Transaction date
Proposed sale
Price
77.57
Quantity 55,000
Value US$4,266,564
Transaction date
Proposed sale
Price
85.93
Quantity 56,960
Value US$4,894,823
Transaction date
Proposed sale
Price
57.99
Quantity 33,481
Value US$1,941,484
Transaction date
Proposed sale
Price
66.10
Quantity 16,669
Value US$1,101,767
Transaction date
Proposed sale
Price
67.14
Quantity 16,292
Value US$1,093,837
Transaction date
Proposed sale
Price
65.43
Quantity 17,349
Value US$1,135,212
Transaction date
Proposed sale
Price
66.04
Quantity 11,616
Value US$767,121
Transaction date
Sale
Price
57.75
Quantity 56,666 -13.8%
Value US$3,272,462
Transaction date
Proposed sale
Price
60.57
Quantity 56,666
Value US$3,432,260
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-16 2026-10-15
PlS Planned sale
71,810 -3.6%
85.63
US$2,263,684 		71,810 -3.6% 85.63 US$2,263,684
2026-10-15 2026-10-15
PrS Proposed sale
68,696
87.48
US$2,299,617 		68,696 87.48 US$2,299,617
2026-09-16 2026-09-15
PlS Planned sale
83,172 -31.7%
228.85
US$619,043 		83,172 -31.7% 228.85 US$619,043
2026-09-15 2026-09-15
PrS Proposed sale
5,400
70.40
US$380,160 		5,400 70.40 US$380,160
2026-08-26 2026-08-25
PlS Planned sale
5,400 -1.5%
74.30
US$401,220 		5,400 -1.5% 74.30 US$401,220
2026-08-25 2026-08-25
PrS Proposed sale
5,400
74.17
US$400,518 		5,400 74.17 US$400,518
2026-05-13 2026-05-11
S Sale
55,000 -13.6%
77.57
US$4,266,350 		55,000 -13.6% 77.57 US$4,266,350
2026-05-11 2026-05-11
PrS Proposed sale
55,000
77.57
US$4,266,564 		55,000 77.57 US$4,266,564
2025-08-14 2025-08-12
S Sale
56,960 -12.2%
85.93
US$4,894,573 		56,960 -12.2% 85.93 US$4,894,573
2025-08-12 2025-08-12
PrS Proposed sale
56,960
85.93
US$4,894,823 		56,960 85.93 US$4,894,823
2024-11-27 2024-11-26
S Sale
3,481 -0.9%
58.30
US$202,942 		3,481 -0.9% 58.30 US$202,942
2024-11-27 2024-11-26
S Sale
30,000 -7.4%
57.95
US$1,738,500 		30,000 -7.4% 57.95 US$1,738,500
2024-11-26 2024-11-26
PrS Proposed sale
33,481
57.99
US$1,941,484 		33,481 57.99 US$1,941,484
2024-05-16 2024-05-14
S Sale
16,669 -4.2%
66.10
US$1,101,821 		16,669 -4.2% 66.10 US$1,101,821
2024-05-14 2024-05-14
PrS Proposed sale
16,669
66.10
US$1,101,767 		16,669 66.10 US$1,101,767
2024-03-08 2024-03-08
PrS Proposed sale
16,292
67.14
US$1,093,837 		16,292 67.14 US$1,093,837
2024-03-08 2024-03-08
S Sale
16,292 -3.8%
67.13
US$1,093,682 		16,292 -3.8% 67.13 US$1,093,682
2024-03-08 2024-03-06
S Sale
28,965 -6.1%
65.52
US$1,897,787 		28,965 -6.1% 65.52 US$1,897,787
2024-03-06 2024-03-06
PrS Proposed sale
17,349
65.43
US$1,135,212 		17,349 65.43 US$1,135,212
2024-03-06 2024-03-06
PrS Proposed sale
11,616
66.04
US$767,121 		11,616 66.04 US$767,121
2023-08-15 2023-08-15
PrS Proposed sale
11,616
60.98
US$708,344 		11,616 60.98 US$708,344
2023-08-15 2023-08-15
S Sale
11,616 -3.2%
61.13
US$710,086 		11,616 -3.2% 61.13 US$710,086
2023-08-15 2023-08-11
S Sale
56,666 -13.8%
57.75
US$3,272,462 		56,666 -13.8% 57.75 US$3,272,462
2023-08-11 2023-08-11
PrS Proposed sale
56,666
60.57
US$3,432,260 		56,666 60.57 US$3,432,260
2022-03-23 2022-03-21
B Purchase
7,224 +4.4%
27.69
US$199,997 		7,224 +4.4% 27.69 US$199,997